HDII (Hypertension Diagnostics) Gross Profit: $0.00 Mil (TTM As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Gross Profit?

Hypertension Diagnostics HDII -99.00% Gross Profit is $0.00 Mil as of Sep. 2019.

Hypertension Diagnostics's gross profit for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics's gross profit for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hypertension Diagnostics's gross profit for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics's Revenue for the three months ended in Sep. 2019 was $0.00 Mil. Therefore, Hypertension Diagnostics's Gross Margin % for the quarter that ended in Sep. 2019 was N/A%.

Hypertension Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage

Hypertension Diagnostics  (OTCPK:HDII) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hypertension Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage

Hypertension Diagnostics Gross Profit Related Terms

Hypertension Diagnostics Gross Profit Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Gross Profit Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.11 0.55 0.75 0.95

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HDII vs ESTRF, OCLN, PTOI: Gross Profit Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics Gross Profit vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Gross Profit falls into.


Hypertension Diagnostics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hypertension Diagnostics's Gross Profit for the fiscal year that ended in Dec. 2018 is calculated as

Gross Profit (A: Dec. 2018 )=Revenue - Cost of Goods Sold
=3.792 - 2.838
=0.95

Hypertension Diagnostics's Gross Profit for the quarter that ended in Sep. 2019 is calculated as

Gross Profit (Q: Sep. 2019 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Hypertension Diagnostics's Gross Margin % for the quarter that ended in Sep. 2019 is calculated as

Gross Margin % (Q: Sep. 2019 )=Gross Profit (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $0.00 Mil mean?
Hypertension Diagnostics (HDII) has a Gross Profit of $0.00 Mil as of Sep. 2019. Gross Profit equals net sales less total cost of goods sold. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Gross Profit too high?
Hypertension Diagnostics' current Gross Profit is $0.00 Mil.
How does Hypertension Diagnostics' Gross Profit compare to ESTRF and OCLN?
Hypertension Diagnostics' Gross Profit of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Diversified Financial Services company?
A good Gross Profit depends on the Diversified Financial Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Gross Profit is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Gross Profit of $0.00 Mil. The current Gross Profit is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Gross Profit is $0.00 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.